Avicanna Inc. (OTCMKTS:AVCNF) Short Interest Up ∞ in August

Avicanna Inc. (OTCMKTS:AVCNF) was the recipient of a significant growth in short interest during the month of August. As of August 31st, there was short interest totaling 38,879 shares, a growth of ∞ from the August 15th total of 0 shares. Based on an average daily volume of 32,741 shares, the days-to-cover ratio is presently 1.2 days.

Avicanna Trading Down 3.4%

OTCMKTS AVCNF opened at $0.08 on Thursday. The business’s 50-day moving average price is $0.09 and its 200 day moving average price is $0.10. Avicanna has a twelve month low of $0.07 and a twelve month high of $0.22.

Avicanna Company Profile

Avicanna Inc, a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets worldwide. It commercializes approximately thirty proprietary evidence-based finished products. The company provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids under the RHO Phyto brand; and indication-specific pharmaceutical products to address unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders, such as Trunerox, an adjuvant treatment for seizures associated with Lennox-Gastaut Syndrome and Dravet Syndrome.